Join to View Full Profile
200 First St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Pedersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Katrina Pedersen is an oncologist in Rochester, MN and is affiliated with the Mayo Clinic. She received her medical degree from Southern Illinois University School of Medicine and has been in practice 8 years. She also speaks multiple languages, including French. She specializes in gastrointestinal cancer and medical oncology.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2016- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
Southern Illinois University School of MedicineClass of 2009
University of IowaMS, Free Radical and Radiation Biology, 2003 - 2005- Grinnell CollegeBA, Biology, French, Art History (Capstone), 1999 - 2003
Certifications & Licensure
MO State Medical License 2016 - 2027
IL State Medical License 2020 - 2026
MN State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha
- CMS Meaningful Use Stage Stage 1 Certification Centricity Patient Online, GE Healthcare, 2013-2017
- CMS Meaningful Use Stage Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2017
Clinical Trials
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Start of enrollment: 2017 Oct 16
- Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer Start of enrollment: 2019 Oct 29
- Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers Start of enrollment: 2020 Jun 01
Publications & Presentations
PubMed
- Translational Relevance of the Genomic Landscape of KRAS-Mutant Colorectal and Pancreatic Cancers.Khalid Jazieh, Jill Tsai, Sheila Solomon, Mojun Zhu, Katrina S Pedersen
Targeted Oncology. 2025-12-11 - Ileal Pouch Adenocarcinoma in a Young Patient With Newly Diagnosed Crohn's-Like Disease of the Pouch.Katie Dunleavy, Katrina Pedersen, Robert Cima, Victor Chedid
The American Journal of Gastroenterology. 2025-11-01 - 4 citationsNeoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.Patrick M Grierson, Crystal Wolf, Rama Suresh, Andrea Wang-Gillam, Benjamin R Tan
Clinical Cancer Research. 2025-09-02
Journal Articles
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersHaeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
Authored Content
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020
Press Mentions
NCCN Clinical Practice Guidelines in Oncology: 2023 UpdatesMay 19th, 2023
Driving Change in Small Bowel AdenocarcinomaNovember 8th, 2019
New NCCN Guideline Focuses on Small-Bowel CancerAugust 6th, 2019
Committees
- Member, Small bowel guideline author, NCCN Guidelines Committee: Colon/Rectal/Anal/Small bowel 2018 - Present
- Member, Physician reviewer, Washington University Institutional Review Board 2017 - Present
- Member, IRCI: Small bowel adenocarcinoma 2015 - Present
Professional Memberships
- Member
- Member
- Member
- European Society for Medical Oncology - ESMOMember
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
